Cytokines and thyroid function

Advances in Neuroimmunology

Volumn 6, Issue 4, 1996, Pages 359-386

  Ajjan, R A ^a   Watson, P F ^a   Weetman, A P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cytokines; Graves' disease; Hashimoto's thyroiditis; interleukins; multinodular goitre; thyroid

Indexed keywords

AMIODARONE; AUTOANTIBODY; CYTOKINE; GLYCOSAMINOGLYCAN; HLA ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; AUTOIMMUNITY; ETIOLOGY; EXOPHTHALMOS; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; IMMUNOGENETICS; INFLAMMATION; RISK FACTOR; SUBACUTE THYROIDITIS; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID FUNCTION;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; THYROID DISEASES; THYROID GLAND;

EID: 0030440830     PISSN: 09605428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-5428(97)00027-7     Document Type: Article

References (260)

1. In situ immune complexes, lymphocyte subpopulations and HLA-DR positive epithelial cells in Hashimoto's thyroiditis
2. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis
3. Detection of IL-12, IL-13 and IL-l5 in the thyroid of patients with autoimmune thyroid disease
4. Cytokine gene expression in extraocular muscles from patients with thyroid associated ophthalmopathy
5. Effects of transforming growth factor-(x on DNA synthesis and thyrotropin-induced iodine metabolism in cultured porcine thyroid cells
6. Effects of tumor necrosis factor-a on the peroxidase content, DR antigen expression and number of microvilli in cultured human thyrocytes
7. Inhibition of human thyroid peroxidase gene expression by IL-1
8. Acquired and naturally occurring resistance of thyroid follicular cells to growth-inhibitory action of TGFß1
9. Hypothyroidism after treatment with interleukin-2 and lymphokine activated killer cells
10. Activated and interferon-γ producing thyroid-derived T cells are detected in Graves' disease thyroid autonomy as well as in non-toxic multinodular goiter
11. Expression of tumour necrosis factor-alpha mRNA and protein in pathological thyroid tissue and carcinoma cell lines
12. Tumor necrosis factor β gene polymorphisms in Graves' disease
13. Induction of autoimmune thyroiditis in chickens by dietary iodine
14. Clonal analysis of T lymphocytes infiltrating the thyroid gland in Hashimoto's thyroiditis
15. Graves' disease: Phenotypic and functional analysis at the clonal level of the T cell repertoire in peripheral blood and in thyroid
16. Pathogenesis of Graves' ophthalmopathy
17. Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration
18. Interleukin-6: A marker of thyroid destructive processes?
19. Serum interleukin-6 in amiodaroneinduced thyrotoxicosis
20. Interleukin-6 and the thyroid
21. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C
22. Stimulation of thyroid cell proliferation by epidermal growth factor is different from cell growth induced by thyrotropin or insulin-like growth factor-I
23. Characterisation of polymorphisms of an interleukin-1 receptor type-l gene (IL-1R1) promoter region (P2) and their relation to insulindependent diabetes-mellitus (IDDM)
24. Recombinant gamma interferon and autoimmune thyroid disease
25. Interleukin-1 receptor antangonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
26. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene
27. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice
28. Interferon-y protects human thyroid epithelial cells against cell-mediated cytotoxicity
29. Inhibitory effects of tumor necrosis factor-(α and interferon-γ on cell mediated cytotoxicity against human thyroid cells
30. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
31. Thyroid hormone and immunological studies in endemic goitre
32. The human interferon- β2/hepatocyte stimulating factor/interleukin-6 gene: DNA polymorphism studies and localization to chromosome 7p21
33. Immunemechanisms in Graves' disease
34. Autoimmune thyroid disease in interferon-treated patients
35. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon
36. Immunology of Graves' ophthalmopathy: retrobulbar histology and histochemistry
37. Simultaneous expression of thyroid peroxidase and humanleukocyte antigen-DR by human thyroid cells. Modulation by thyrotropin, thyroid-stimulating antibody, and interferon-γ
38. The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation
39. The effect of iodine depletion and supplementation in the Buffalo strain rat
40. Acute effects of interferon-α administration on thyroid hormone metabolism in healthy men
41. Transforming growth factor β1 synthesis in human thyroid follicular cells
42. Cytokines as genetic modifying factors in immune and inflammatory diseases
43. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM
44. Endocrine effects of IL-1α and IL-1β administered in a phase I trial to patients with advanced cancer
45. Lack of association between an interleukin-1 antagonist polymorphism and systemic lupus erythematosus
46. Coculture of human thyroid monolayer cells and autologous T cells: impact of HLA class II antigen expression
47. A genome-wide search for human type 1 diabetes susceptibility genes
48. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness
49. Cytolytic T cells with Thl-like cytokine profile predominate in retrobulbar lymphocytic infiltrates of Graves' ophthalmopathy
50. Enhanced production of γ-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis
51. High potential to tumour necrosis factor-α production of thyroid infiltrating lymphocytes in Hashimoto's thyroiditis: A peculiar feature of thyroid autoimmunity
52. Human IL-10 is produced by both type 1 helper (Thl) and type 2 helper (Th2) cell clones and inhibits their antigen-specific proliferation and cytokine production
53. Polymorphism of the T cell receptor β-chain in Grave's disease
54. In vitro effects of tumor-necrosisfactor-alpha on human thyroid follicular cells
55. Interleukin-6 production by thyroid epithelial cells
56. Interleukin-1 and interleukin-1 antagonism
57. The sick euthyroid syndrome: Changes in thyroid hormone serum parameters and hormone metabolism
58. Cloning and sequencing of a 64 kDa autoantigen recognised by patients with autoimmune thyroid disease
59. Human recombinant IL-β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats
60. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease
61. Biosynthesis of corticotropin-releasing hormone in human T -lymphocytes
62. Association between autoimmune thyroid disease and familial Alzheimer's disease
63. Primary hypothyroidism associated with interferon therapy of breast cancer
64. An interleukin-8 (IL-8) cDNA clone identifies a frequent HindIII polymorphism
65. A new murine CD4+ T cell subset with an unrestricted cytokine profile
66. Thyrotropin receptor antibodies following treatment with recombinant (x-interferon in patients with hepatitis
67. Age associated changes in Epstein-Barr virus induced human lymphocyte autoantibody production
68. Expression of the Herrmes-1 (CD44) and ICAM-1 (CD54) molecule on the surface of thyroid cells from patients with Graves' disease
69. Antiproliferative effect of IFN-gamma in immune regulation
70. Polarization of Th-cell response: A phylogenetic consequence of nonspecific immune defence?
71. Thyroid autoimmunity and autoimmune hypothyroidism during long-term treatment with recombinant interferon-alpha
72. Anti-IL-4 diminishes in vivo priming for antigenspecific IL-4 production by Tcells
73. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: Thyroid follicular cells produce interleukin-1 and interleukin-6
74. CD4+ Tcell clones from autoimmune thyroid tissue cannot be classified according to their lymphokine production
75. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognise autologous fibroblasts
76. *04-bearing haplotypes in rheumatoid-arthritis patients
77. Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma containing lymphocytes in human thyroid autoimmune disease
78. Continuous infusion of interleukin-1 induces a nonthyroidal illness syndrome in the rat
79. Different cytokine mRNA profile in Graves' disease Hashimoto's thyroiditis and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RTPCR)
80. Increased induction of HLA-DR by interferon-y in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy
81. Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease
82. Immunohistochemical detection and localization of a 72-kilodalton heat shock protein in autoimmune thyroid disease
83. Cell surface localization of a 72 kilodalton heat shock protein in retro-ocular fibroblasts from patients with Graves' ophthalmopathy
84. Enhanced induction of a 72 kDa heat shock protein in cultured retro-ocular fibroblasts
85. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retro-ocular fibroblasts
86. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts
87. Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy
88. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists
89. Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Graves' ophthalmopathy
90. Contribution of interleukin (IL)-10 promoter polymorphism to allergic inflammation
91. Reversible thyroid dysfunction during treatment with GM-CSR
92. Human fetal thyroid cell growth in vitro: System characterization and cytokine inhibition
93. Autoimmune endocrine disease induced by recombinant IFN-a therapy for chronic active type C hepatitis
94. Analysis of proteoglycan synthesis by retroocular tissue fibroblasts under the influence of interleukin-1β and transforming growth factor β-1
95. Augmented interleukin-6 production by rat thyrocytes (FRTL-5): Effects of interleukin-1β and thyroid stimulating hormone
96. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Grave's thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre
97. Influence of the HLA-DR4 antigen and iodide status on the developement of autoimmune postpartum thyroiditis
98. Sequence homologies between hsp60 and autoantigens
99. Interleukin-6 an endocrine cytokine
100. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy
101. Suppression of thyrotropin-releasing hormone gene expression by interleukin-β1 in the rat: Implication for non-thyroidal illness
102. Autocrine or paracrine inflammatory actions of corticotropin releasing hormone in vivo
103. Immunohistochemical study of intrathyroidal lymph follicles
104. Interleukin-1 production and action in thyroid tissue
105. Induction of experimental thyroiditis in mice by recombinant interferon-γ administration
106. Immunohistochemical localization of interleukin-1 and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders
107. Thl and Th2 subsets: Paradigms lost?
108. Release of interleukin-6 by human thyroid epithelial cells immortalized by simian virus 40 DNA transfection
109. Interleukin-1 inhibits human thyroid carcinoma cell growth
110. Stimulation of glycosaminoglycan production in cultured human retro-ocular fibroblasts
111. Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone
112. Interferongamma inhibits thyrotropin-induced thyroglobulin gene transcription in cultured human thyrocytes
113. Effects of interferon-gamma therapy on thyroid function, T -lymphocyte subpopulations and induction of autoantibodies
114. Thyroid functions in patients treated with interleukin-2 and lymphokine-activated killer cells
115. The heat shock response
116. Development of thyroid-disease during therapy of chronic viral-hepatitis with interferon-α
117. The pathology of autoimmune thyroid disease: A review
118. Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells
119. Cytokine and the endocrine system II Roles in substrate metabolism modulation of thyroidal and pancreatic endocrine cell functions and autoimmune endocrine disease
120. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy
121. Thyroid dysfunction induced by recombinant interferon in patients with chronic hepatitis C: a prospective study
122. Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis-C
123. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon gamma
124. Cytokines and thyroid autoimmunity
125. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis
126. Treatment of chronic type B hepatitis with recombinant a-interferon induces autoantibodies not specific for autoimmune chronic hepatitis
127. Iodine: an influence on the development of thyroid autoimmune disease?
128. Cytokine, thyroid autoantibody synthesis and thyroid cell survival in culture
129. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue
130. Genetics of autoimmune disease
131. Polymorphic structure of the tumor necrosis factor (TNF) locus - an Ncol polymorphism in the Ist intron of the human TNF-R gene correlates with a variant amino-acid in position 26 and a reduced level of the TNF-β production
132. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia Possible role in thyroid-associated ophthalmopathy
133. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT)
134. Distinctive modulation by IL-4 and IL-10 of the effector function of marine thyroglobulin-primed cells in transfer-experimental autoimmune thyroiditis
135. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Grave's disease and Hashimoto's thyroiditis
136. Effects of rat gamma and non-gamma interferons on the expression of la antigen, growth and differentiated functions of FRTL-5 cells
137. Induction in vitro of 72-kD heat shock protein in a continuous culture of rat thyroid cells, FRTL-5
138. Demonstration of interleukin-1 on perifollicular endothelial cells in the thyroid glands of patients with Graves' disease
139. Enhanced expression of transforming growth factor-1 in rat-thyroid hyperplasia is thyrotropin induced and time-dependent
140. ThI and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties
141. The expanding universe of T -cell subsets Thl Th2 and more
142. Transfection of thyroid autoantigens into EBV-transformed B cell lines: Recognition by Graves' disease thyroid T cells
143. Identification of thyroid-stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfectedEpstein-Barr virus-transformed B cell lines
144. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis in mice by recombinant IL-1β.
145. IgG heavy chain allotype (Gm) in atrophic and goitrous thyroiditis
146. Actions of epidermal growth factor and its receptor in the thyroid
147. Interferon- inhibition of human thyrotropin receptor gene expression
148. Effect of interleukin-6 on cell proliferation of FRTL-5 cells
149. Lack of disease-associated HLA-DQ restriction-fragment-length-polymorphisms in families with autoimmune thyroid-disease
150. Tumor necrosis factor- decreases thyrotropin-induced 5′-deiodinase activity in FRTL-5 thyroid cells
151. Effects of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice
152. Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases
153. Impairment of hypothalamic-pituitarythyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin)
154. Suppression of rat thyrotroph and thyroid cell function by tumour necrosis factor-α
155. Adhesion molecules in the pathogenesis of thyroid associated ophthalmopathy
156. Lack of intrathyroidal tumour necrosis factor alpha in Graves' disease
157. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis
158. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid-associated ophthalmopathy
159. Stimulation of proliferation and inhibition of function of xenotransplanted human thyroid-tissue by epidermal growth-factor
160. Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells
161. The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis
162. Transforming growth factor R-1 expression in proliferating thyroid disease
163. T-cell receptor R-chain polymorphisms in Graves' disease
164. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2α
165. Stressful life events in the pathogenesis of Graves' disease
166. Interleukin-1 affects the function of cultured human thyroid cells
167. Influence of tumour necrosis factor-β and interferon-γ, separately and added together with interleukin-1β, on the function of cultured human thyroid cells
168. Heat shock protein 70 (HSP70) and complement C4 genotypes in patients with hyperthyroid Graves' disease
169. Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease
170. Genetics of autoimmune thyroid disease: Lack of evidence for linkage to HLA within families
171. Autoimmunity after alpha-interferon treatment for malignant carcinoid tumors
172. Stressful life events and Graves' disease
173. Tumor-necrosis factor polymorphisms in multiplesclerosis - no additional association independent of HLA
174. In situ hybridization of the messenger mRNA for interferon-γ, interferon-α, interferon-β, interleukin-1β and interleukin-6 and characterization of infiltrating cells in thyroid tissues
175. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities
176. Autoantibodies and response to alpha-interferon in patients with chronic viral-hepatitis
177. 125I organification and thyroid hormone release by interleukin-1, tumour necrosis factoralpha and interferon-gamma in human thyrocytes in suspension culture
178. Pathogenesis of autoimmune hypothyroidism induced by lymphokine-activated killer (LAK) cell therapy: in vitro inhibition of human thyroid function by interleukin-2 in the presence of autologous intrathyroidal lymphocytes
179. Primary hypothyroidism associated with interleukin-2 and interferon-2 therapy of melanoma and renal-carcinoma
180. Induction of hyperthyroidism by interferon alpha 2b
181. Expression levels of the thyrotropin receptor gene in autoimmune thyroid disease: coregulation with parameters of thyroid function and inverse relation to major histocompatibility complex classes I and II
182. Presence of immunoreactive corticotropin-releasing hormone in thyroid lesions
183. Acquisition of lymphokine producing phenotypes by CD4+Tcells
184. Effects of interleukins on EGFstimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells
185. Connective tissue, glycosaminoglycans, and diseases of the thyroid
186. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene
187. Life events in the pathogenesis of Graves' disease. A controlled study
188. Efects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans
189. Cellular immunity and retrobulbar fibroblasts in Graves' ophthalmopathy
190. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Thl and Th2 cells
191. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets: Characterization of thyroiditis-inducing T cell lines and clones derived from thyroid lesions
192. Self-thyroid epithelial-cell (TEC)reactive CD8+ T-cell clones derived from autoimmune-thyroiditis lesions: they recognize selfthyroid antigens directly on TEC to exhibit T-helper cell 1-type lymphokine production and cytotoxicity against TEC
193. IL-4 and IFN-γ direct the development of distinct subsets of helper T cells
194. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1beta infusion: In vivo and in vitro studies
195. Resistance to autoimmune thyroid disease is associated with HLA-DQ
196. Interleukin-I(IL-1) receptor antagonist and soluble IL-Ireceptor inhibit IL-l-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy
197. Adhesion molecule expression by the FRTL-5 rat thyroid cell line
198. The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells
199. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells
200. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease
201. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): Prevention of disease and decrease of EAT specific T cells
202. Tumor necrosis factor-ot and interferon-γ modulate gene expression of type I 5′-deiodinase, thyroid peroxidase and thyroglobulin in FRTL-5 rat thyroid cells
203. Polymorphism in the human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 by tandem repeat
204. Severity of alopecia areata is associated with a polymorphism in the Interleukin-1 receptor antagonist gene
205. General inhibition by transforming growth factor-1 of thyrotropin and cAMP responses in human thyroid cells in primary culture
206. Effects of tumour necrosis factor and interferongamma on thyroid cells
207. Epidermal growthfactor and transforming growth factor-alpha suppress HLA class-II induction in human thyroid epithelial-cells
208. Infections and autoimmune endocrine disease. Bailliere's Clin
209. Interleukin-6 inhibits human thyroid peroxidase gene expression
210. High prevalence of Hashimoto thyroiditis in femalepatients with chronic hepatitis-C prior to treatment by interferon
211. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis-C before interferon therapy
212. Do heat shock proteins play a role in Graves' disease? Heat shock protein-specific T cells from Graves' disease thyroids do not recognize thyroid epithelial cells
213. Interleukin- 12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
214. The spectrum of thyroid disease in the comunity; the Whickham survey
215. Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man
216. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis
217. Hypothyroidism and goitre during interleukin-2 therapy without LAK cells
218. Influence of IL-1 receptor blockade on the human response to endotoxemia
219. Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells Induction by cytokines and overexpression in autoimmune glands
220. Effects of interleukin-1 administration on pituitaryadrenal and pituitary-thyroid axes function of patients with ovarian cancer
221. Acute thyroid dysfunction after therapy with interleukin-2
222. Incidence rate and risk-factors for thyroiddysfunction during recombinant interleukin-2 therapy in advanced malignancies
223. Thyroid-associated ophthalmopathy - a model for the association of organspecific autoimmune disorders
224. The risk factor for development of thyroid-disease during interferonalpha therapy for chronic hepatitis-C
225. Analysis of cytokine gene expression in Graves' disease and multinodular goiter
226. Semi-quantitative analysis of interleukin-l-, interleukin-6 and interleukin-8 mRNA expression by human thyrocytes
227. Regulation of major histocompatibility complex class II antigen expression by the FRTL-5 rat thyroid cell line
228. T -cell receptor alpha chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' di sease
229. Immunoglobulin allotypes in Graves' disease
230. Synergistic effects of recombinant tumour necrosis factor(TNF) and-γ-interferon (γ-IFN) on rat thyroidal cell growth and la antigen expression
231. Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells
232. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy
233. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy
234. Regulation of interleukin-6 release by human thyrocytes
235. Functional analysis of intercellular adhesion molecule-1-expressing human thyroid cells
236. Thyroid-associated eye disease: Pathophysiology
237. Autoimmune thyroiditis: predisposition and pathogenesis
238. Thyroid follicular cells produce interleukin-8
239. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells
240. Autoimmune thyroid disease: further developments in our understanding
241. Antigen presentation in the pathogenesis of autoimmune thyroid disease
242. Infection and endocrine autoimmunity
243. Vitiligo and Graves' disease following treatment of malignant melanoma with recombinant human IL-4
244. Effects of interleukin-1 alpha on porcine thyroid follicle in suspension culture
245. the immunoregulatory influence of transforming growth factor-β (TGFβ) in thyroid autoimmunity: TGF inhibits autoreactivity in Graves' disease
246. Genetics of tumour necrosis factor-ot in autoimmune, infectious, and neoplastic diseases
247. IL-I R modulation of spontaneous autoimmune diabetes and thyroiditis in BB rats
248. Stressful life events and Graves' disease
249. Dissociation between serum interleukin-6 rise and other parameters of disease activity in subacute thyroiditis during treatment with corticosteroids
250. Interleukin-1 inhibits thyrotrophin-induced human thyroglobu lin gene expression
251. Reversible inhibition by interferons alpha and beta of 1251 incorporation and thyroid hormone release by human thyroid follicles in vitro
252. Influence of cytokines on growth and differentiated function of FRTL-5 cells
253. Effects of interleukin-1 on growth and adenosine 3',5'-monophosphate generation of the rat thyroid cell line, FRTL-5 cells
254. Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM 1
255. Restricted tissue reactivity of autoantibodies to a 64 kDa eye muscle membrane antigen in thyroidassociated ophthalmopathy
256. Detection of interleukin-6 an interleukin-1 production in human thyroid epithelial cells by nonradioactive in situ hybridization and immunohistochemical methods
257. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells
258. Evidence that Thl lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat
259. Cytokine gene expression in islets and thyroids of BB rats